{"id":"https://openalex.org/W58885487","doi":null,"title":"Echinocandins: pharmacokinetic and therapeutic issues.","display_name":"Echinocandins: pharmacokinetic and therapeutic issues.","publication_year":2009,"publication_date":"2009-07-01","ids":{"openalex":"https://openalex.org/W58885487","mag":"58885487","pmid":"https://pubmed.ncbi.nlm.nih.gov/19557937"},"language":"en","primary_location":{"id":"pmid:19557937","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19557937","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Evaluation Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021369714","display_name":"John Douglas Cleary","orcid":"https://orcid.org/0000-0001-7599-5995","observed_orcids":["https://orcid.org/0000-0001-7599-5995"]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John D Cleary","raw_affiliation_strings":["Antimycotic Research Laboratory, University of Mississippi Medical Center, School of Pharmacy, Department of Medicine, Division of Infectious Diseases, Jackson, MS 39216, USA. jcleary@medicine.umsmed.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antimycotic Research Laboratory, University of Mississippi Medical Center, School of Pharmacy, Department of Medicine, Division of Infectious Diseases, Jackson, MS 39216, USA. jcleary@medicine.umsmed.edu","institution_ids":["https://openalex.org/I29606459"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021369714"],"corresponding_institution_ids":["https://openalex.org/I29606459"],"apc_list":null,"apc_paid":null,"fwci":1.6104,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.81579951,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"25","issue":"7","first_page":"1741","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/echinocandins","display_name":"echinocandins","score":0.9940000176429749},{"id":"https://openalex.org/keywords/caspofungin","display_name":"caspofungin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/micafungin","display_name":"micafungin","score":1.0},{"id":"https://openalex.org/keywords/anidulafungin","display_name":"anidulafungin","score":1.0},{"id":"https://openalex.org/keywords/invasive-candidiasis","display_name":"invasive candidiasis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/candidiasis","display_name":"candidiasis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/antifungal-resistance","display_name":"antifungal resistance","score":0.7599999904632568},{"id":"https://openalex.org/keywords/azole-resistance","display_name":"azole resistance","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8859999775886536},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4819999933242798},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C2910751997","wikidata":"https://www.wikidata.org/wiki/Q3718510","display_name":"Echinocandins","level":5,"score":0.9600787162780762},{"id":"https://openalex.org/C2780402444","wikidata":"https://www.wikidata.org/wiki/Q420875","display_name":"Caspofungin","level":4,"score":0.9057420492172241},{"id":"https://openalex.org/C2776222947","wikidata":"https://www.wikidata.org/wiki/Q4764531","display_name":"Anidulafungin","level":5,"score":0.8354000449180603},{"id":"https://openalex.org/C2779020398","wikidata":"https://www.wikidata.org/wiki/Q6827850","display_name":"Micafungin","level":4,"score":0.7915632724761963},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6974732875823975},{"id":"https://openalex.org/C2779320740","wikidata":"https://www.wikidata.org/wiki/Q3718510","display_name":"Echinocandin","level":4,"score":0.6818304061889648},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6399756073951721},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.49161607027053833},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.451140433549881},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4313090741634369},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.41301652789115906},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.31715935468673706},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2001558244228363},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025141","descriptor_name":"Drug Resistance, Fungal","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054796","descriptor_name":"Drug Dosage Calculations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:19557937","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19557937","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Evaluation Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7219276716","https://openalex.org/W7000049588","https://openalex.org/W2917702355","https://openalex.org/W2102739518","https://openalex.org/W3114248846","https://openalex.org/W1991585482","https://openalex.org/W2048260460","https://openalex.org/W7096200967","https://openalex.org/W2601911288","https://openalex.org/W2083352990"],"abstract_inverted_index":{"Invasive":[0],"infections":[1,49],"caused":[2,50],"by":[3,51,158],"Candida":[4,90],"species":[5,52,91],"are":[6,56,69,138,143,155],"a":[7,77,86],"major":[8,123],"concern":[9,40],"today":[10],"due":[11],"to":[12,58,97,125,161],"increasing":[13],"numbers":[14,47],"of":[15,21,28,48,73,80,89,166,179,192],"at-risk":[16],"patients":[17],"and":[18,31,82,92,112,133,135,146,188],"high":[19],"rates":[20],"mortality,":[22],"as":[23,25,63],"well":[24],"increased":[26],"length":[27],"hospital":[29],"stays":[30],"healthcare":[32],"costs":[33],"associated":[34],"with":[35],"these":[36],"infections.":[37],"An":[38],"additional":[39],"is":[41],"the":[42,70,106,117,128,163,175,180,184,189,193],"current":[43],"trend":[44],"towards":[45],"greater":[46],"or":[53,65,99],"strains":[54],"that":[55],"resistant":[57,96],"traditional":[59],"antifungal":[60],"agents,":[61],"such":[62],"fluconazole":[64],"other":[66],"triazoles.":[67],"Echinocandins":[68],"newest":[71],"class":[72],"antifungals.":[74],"They":[75],"have":[76,103,120],"unique":[78],"mechanism":[79],"action,":[81],"exhibit":[83],"activity":[84],"against":[85],"broad":[87],"range":[88],"strains,":[93],"including":[94],"those":[95],"azoles":[98],"polyenes.":[100],"Few":[101],"studies":[102],"directly":[104],"compared":[105],"three":[107],"approved":[108,177],"echinocandins":[109,129,154],"(caspofungin,":[110],"micafungin,":[111],"anidulafungin)":[113],"for":[114],"efficacy,":[115],"but":[116],"existing":[118],"data":[119,187],"not":[121,149],"suggested":[122],"differences":[124],"date.":[126],"All":[127],"possess":[130],"excellent":[131],"tolerability":[132],"safety,":[134],"although":[136],"there":[137],"some":[139],"pharmacokinetic":[140],"differences,":[141],"they":[142],"relatively":[144],"small":[145],"generally":[147],"do":[148],"influence":[150],"drug":[151],"selection.":[152],"Consequently,":[153],"now":[156],"considered":[157],"most":[159,185,190],"experts":[160],"be":[162],"first-line":[164],"treatment":[165],"invasive":[167],"candidiasis":[168],"in":[169],"critically":[170],"ill":[171],"patients.":[172],"Caspofungin":[173],"was":[174],"first":[176],"member":[178],"class;":[181],"it":[182],"has":[183],"available":[186],"indications":[191],"echinocandins.":[194]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}